HyTest’s revenue and operating profit continues to grow
HyTest is one of the world’s leading companies in the immunodiagnostics reagents business. Indeed, its products are sold in no less than 50 countries throughout the world. During the last fiscal year HyTest’s consolidated revenue was 24.1 million euros, which equated to a year-on-year growth of 1.3%. This rate was low due to the exceptionally strong growth experienced in 2016.
